STONKWHISPER
← Back to Intel
Insider ActivityMLYS

Rodman David Malcom, Chief Medical Officer at Mineralys Therapeutics, Inc., sold $152K of MLYS

Updated Jun 18, 2026
Rodman David Malcom Chief Medical Officer
Mineralys Therapeutics, Inc. · $MLYS
$152K Total Value
6,349 Shares Traded
$23.9252 Price / Share
63,443 Shares Owned After
2026-06-12 Filing Date

Transaction Details

InsiderRodman David Malcom
TitleChief Medical Officer
CompanyMineralys Therapeutics, Inc.
TickerMLYS
Transaction TypeSale
Transaction Date2026-06-12
Shares Traded6,349
Price Per Share$23.9252
Total Value$152K
Filed Date2026-06-12
Accession Number0001672659-26-000030

Ownership Context

Shares Owned After Transaction63,443
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001672659-26-000030

Other Insider Trades — MLYS

Other Trades by Rodman David Malcom

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →

Track MLYS insider activity in real time on The Wire →

Get alerts when Rodman David Malcom files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:01 UTC

Want real-time data? Access The Wire for live sentiment tracking.